Association of abstinence time with semen quality and fertility outcomes: a systematic review and dose–response meta-analysis

Abstract

Background: Infertility affects 186 million people worldwide, with male factors contributing to 50% of infertility cases. Semen analysis is a key for diagnosing male factor infertility, but sperm parameters can be influenced by ejaculatory abstinence (EA) duration. Shortening or prolonging EA can impact on semen quality and assisted reproductive technology (ART) outcomes, but the optimal EA duration remains unclear, particularly for infertility patients. Objectives: This study conducts a comprehensive meta-analysis to explore the impact of varying abstinence durations on semen quality and fertility outcomes. Methods: Three English database (PubMed, Embase, and Cochrane Central Register of Controlled Trials) as well as four Chinese database (China National Knowledge Infrastructure, Chinese Scientific Journals database, WanFang database, and Chinese Biomedical Literature database) were searched from 2000 to August 2023. The classical meta-analysis and “one-stage” dose–response meta-analysis were conducted to compare the associations of different abstinence durations (short-term abstinence vs. long-term abstinence) on semen quality in healthy adult and different type of infertile patients. Results: There were 85 eligible studies were finally included. The meta-analysis of volume (mean difference [MD] = −0.95 mL, 95% confidence interval [CI]: −1.16 to −0.74 mL), total sperm count (TSC) (MD = −102.45×106, 95% CI: −117.98×106 to −86.91×106), sperm concentration (SC) (MD = −11.88×106/mL, 95% CI: −18.96×106/mL to −4.80×106/mL), DNA fragmentation index (DFI) (MD = −2.37%, 95% CI: −4.73% to −0.01%) in healthy men showed a significant decrease with different abstinence durations (short-term abstinence vs. long-term abstinence). The meta-analysis of infertile men showed significant decrease in volume in various subgroups (MD range: −0.73 to −1.17 mL) with P < 0.01; TSC (MD = −61.93×106, 95% CI: −88.84×106 to −35.01×106), SC (MD = −5.39×106/mL, 95% CI: −9.97×106 to −0.81×106/mL), DFI (MD = −5.63%, 95% CI: −10.19% to −1.06%) in unexplained infertility subgroup; significant increase in viability (MD = 6.14%, 95% CI: 3.61% to 8.68%) in the unexplained infertility subgroup. The dose–response meta-analysis showed that TSC in oligozoospermia showed a nonlinear increase (coefficient from 3.38 to −5.76, P from 0.02 to 0.22) and the truncation point was around the 4th to 5th abstinence day. The percentage of progressive motile sperm (PR) in asthenozoospermia showed a significant decrease (coefficient = −2.39, 95% CI: −4.28 to −0.50). For fertility outcomes of different ARTs, only the clinical pregnancy rate (CPR) in the intrauterine insemination (IUI) subgroup showed a significant decrease around the 3rd day (coefficient = 0.85, 95% CI: 0.75 to 0.97). Conclusions: Short-term abstinence may be associated with limited improvements in semen quality in healthy men but could be more beneficial for infertile men, especially within the first 4 days of abstinence. Caution is urged in making definitive conclusions about the causal relationship between abstinence time and semen quality changes due to potential confounding and interactions.